Senior insider sale
Head of R&D, CMO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$609.4K
34.28K shares
What this filing means
BOTWOOD NICHOLAS A.J. plans to sell 34.28K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $609.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2026ACC: 0001959173-26-004566
Officer· Head of R&D, CMO
Since Feb 2026
34.28K
Shares to sell
$609.4K
Approx. market value
34.28K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
6/11/2026
22.52KRestricted Stock Vesting
Compensation
5/16/2025
200.00Open Market Purchase
Cash
5/16/2025
11.56KTotal acquired34.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/11/2026 | Stock Option Exercise Cash | 22.52K | — |
5/16/2025 | Restricted Stock Vesting Compensation | 200.00 | — |
5/16/2025 | Open Market Purchase Cash | 11.56K | — |
| Total | 34.28K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
34.28K
Market value
$609.4K
6/11/2026
Total
Units
34.28K
Value
$609.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/11/2026 | 34.28K | $609.4K | NASDAQ | Planned |
| Total | 34.28K | $609.4K | ||